ACADIA PHARMACEUTICALS INC. Public Float
ACADIA PHARMACEUTICALS INC. (ACAD) had Public Float of $2.30 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $2.30B.
- 2024-06-28: Entity Public Float $2.00B.
- 2023-06-30: Entity Public Float $2.90B.
- 2022-06-30: Entity Public Float $1.70B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $2.30B 10-K · filed 2026-02-26 |
| 2024-06-28 | $2.00B 10-K · filed 2025-02-27 |
| 2023-06-30 | $2.90B 10-K · filed 2024-02-28 |
| 2022-06-30 | $1.70B 10-K · filed 2023-02-28 |
| 2021-06-30 | $2.50B 10-K · filed 2022-03-01 |
| 2020-06-30 | $4.60B 10-K · filed 2021-02-25 |
| 2019-06-28 | $2.20B 10-K · filed 2020-02-27 |
| 2018-06-29 | $1.20B 10-K · filed 2019-02-27 |
| 2017-06-30 | $2.10B 10-K · filed 2018-02-27 |
| 2016-06-30 | $2.30B 10-K · filed 2017-02-28 |
| 2015-06-30 | $2.60B 10-K · filed 2016-02-29 |
| 2014-06-30 | $1.40B 10-K · filed 2015-02-26 |
| 2013-06-30 | $1.00B 10-K · filed 2014-02-27 |
| 2012-06-30 | $92.80M 10-K · filed 2013-03-12 |
| 2011-06-30 | $85.70M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |